C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis

Stroke

Volumn 32, Issue 12, 2001, Pages 2748-2752

  Johnston, S Claiborne ^a   Messina, Louis M ^a   Browner, Warren S ^b   Lawton, Michael T ^a   Morris, Caroline ^a   Dean, Deborah ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Atherosclerosis; C reactive protein; Carotid arteries; Chlamydia pneumoniae; Inflammation

Indexed keywords

BACTERIAL RNA; C REACTIVE PROTEIN; MESSENGER RNA;

ARTICLE; ATHEROSCLEROSIS; BACTERIUM IDENTIFICATION; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STROKE; TISSUE PREPARATION;

EID: 0035207958     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/hs1201.099631     Document Type: Article

References (42)

1. C-reactive protein: A critical review
2. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
3. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
4. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
5. Inflammatory markers of coronary risk
6. Atherosclerosis: An inflammatory disease
7. The pathogenesis of atherosclerosis: Atherogenesis and inflammation
8. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: Results at autopsy
9. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina: Histological data on 14 autopsied patients
10. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)
11. Strandness ED, Wang SP. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
12. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis: The Chlamydia pneumoniae Atherosclerosis Study Group
13. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease
14. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
15. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque
16. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes
17. Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens
18. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
19. Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction
20. Chlamydia pneumoniae and atherosclerosis: Links to the disease process
21. Chronic infections and coronary heart disease: Is there a link?
22. Chlamydia pneumoniae: Inflammation and instability of the atherosclerotic plaque
23. Inflammation, infection, and cardiovascular risk: How good is the clinical evidence?
24. Infections, inflammation, and the risk of coronary heart disease
25. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease
26. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
27. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women
28. Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
29. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: Negative results of a case-control study
30. Chlamydia pneumoniae cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
31. Elevation of C-reactive protein in "active" coronary artery disease
32. Major outer membrane protein variants of Chlamydia trachoimatis are associated with severe upper genital tract infections and histopathotogy in San Francisco
33. Molecular identification of an avian strain of Chlamydia psittaci causing severe keratoconjunctivitis in a bird fancier
34. Causes and outcomes of the acute chest syndrome in sickle cell disease: National Acute Chest Syndrome Study Group
35. Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae
36. Characterization of the immune response in conjunctival scarring due to Chlamydia trachomatis among Vietnamese patients
37. Constructing polycompetitor cDNAs for quantitative PCR
38. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae
39. C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo
40. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: The final report of the ROXIS Study
41. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: Primary clinical results of the ACADEMIC study
42. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease